Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
36
Política y gobierno
36
Aspectos sociales
29
Filosofía
23
Crítica e interpretación
20
Condiciones sociales
19
Novela mexicana
18
Condiciones económicas
17
Capitalismo
16
Aspectos económicos
13
Política económica
13
Actividad política
11
Economía marxista
9
Estudio y enseñanza
9
Aspectos políticos
8
Democracia
8
Historia y crítica
8
Mujeres
8
Socialismo
8
Globalización
7
Neoliberalismo
7
Aspectos morales y éticos
6
Comunismo
6
Relaciones económicas exteriores
6
Campesinos
5
Desarrollo económico
5
Movimientos sociales
5
Abastecimiento de agua
4
Agricultura
4
Aspectos ambientales
4
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8por Romero-López, TorcuatoEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9por Petracci, Elisabetta, Scarpi, Emanuela, Passardi, Alessandro, Biggeri, Annibale, Milandri, Carlo, Vecchia, Stefano, Gelsomino, Fabio, Tassinari, Davide, Tamberi, Stefano, Bernardini, Ilaria, Accettura, Caterina, Frassineti, Giovanni Luca, Amadori, Dino, Nanni, Oriana“…The ITACa trial consisted of two arms: first-line chemotherapy (CT)+B followed by second-line CT alone versus first-line CT alone followed by second-line CT+B or CT+B+cetuximab according to KRAS status. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10por Casadei Gardini, Andrea, Scarpi, Emanuela, Orlandi, Elena, Tassinari, Davide, Leo, Silvana, Bernardini, Ilaria, Gelsomino, Fabio, Tamberi, Stefano, Ruscelli, Silvia, Vespignani, Roberto, Ronconi, Sonia, Frassineti, Giovanni Luca, Amadori, Dino, Passardi, Alessandro“…BACKGROUND: The aim of this study was to investigate the role of pre-treatment aspartate aminotransferase-lynphocyte ratio (ALRI) as a predictor of prognosis and treatment efficacy in patients with metastatic colorectal cancer (mCRC) enrolled in the prospective multicenter randomized ITACa (Italian Trial in Advanced Colorectal Cancer) trial to receive first-line chemotherapy (CT) + bevacizumab (B) or CT alone. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11por Gardini, Andrea Casadei, Carloni, Silvia, Scarpi, Emanuela, Maltoni, Paolo, Dorizzi, Romolo M., Passardi, Alessandro, Frassineti, Giovanni Luca, Cortesi, Pietro, Giannini, Maria Benedetta, Marisi, Giorgia, Amadori, Dino, Lucchesi, Alessandro“…Serum samples from 132 ITACa patients were collected at baseline and 2 months after starting first-line chemotherapy. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12por Casadei Gardini, Andrea, Scarpi, Emanuela, Valgiusti, Martina, Monti, Manlio, Ruscelli, Silvia, Matteucci, Laura, Bartolini, Giulia, Vertogen, Bernadette, Pagan, Flavia, Rovesti, Giulia, Frassineti, Giovanni Luca, Passardi, Alessandro“…Our aim was to evaluate the prognostic and/or predictive capacity of the MII in the randomized ITACa (Italian Trial in Advanced Colorectal Cancer) study on patients with metastatic colorectal cancer undergoing first-line chemotherapy. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13por Passardi, Alessandro, Scarpi, Emanuela, Gelsomino, Fabio, Palladino, Maria Angela, Casadei Gardini, Andrea, Turci, Daniele, Chiuri, Vincenzo Emanuele, Mucciarini, Claudia, Tassinari, Davide, Ragazzini, Angela, Frassineti, Giovanni Luca, Valgiusti, Martina, Ulivi, Paola, Amadori, Dino“…The ITACa trial was designed to define the role of cetuximab (Cet) and bevacizumab (Bev) in combination with standard chemotherapy (CT, FOLFIRI or FOLFOX4) as first- and second-line treatment in metastatic colorectal cancer. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14por Parente, Roberta, Sartorio, Silvio, Brussino, Luisa, De Pasquale, Tiziana, Zoli, Alessandra, Agolini, Stefano, Di Agosta, Ester, Quattrocchi, Paolina, Borrelli, Paolo, Bignardi, Donatella, Petraroli, Angelica, Senter, Riccardo, Popescu Janu, Valentina, Cogliati, Chiara, Guarino, Maria Domenica, Rossi, Oliviero, Firinu, Davide, Pucci, Stefano, Spadaro, Giuseppe, Triggiani, Massimo, Cancian, Mauro, Zanichelli, Andrea“…Adult patients with AE-C1-INH, followed by Reference Centers belonging to the Italian Network for Hereditary and Acquired Angioedema (ITACA), were enrolled in this study. Patients received nucleoside-modified mRNA vaccines and vaccines with adenovirus vectors. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15por Cancian, Mauro, Triggianese, Paola, Modica, Stella, Arcoleo, Francesco, Bignardi, Donatella, Brussino, Luisa, Colangelo, Caterina, Di Agosta, Ester, Firinu, Davide, Guarino, Maria Domenica, Giardino, Francesco, Giliberti, Marica, Montinaro, Vincenzo, Senter, Riccardo“…METHODS: Retrospective data were collected through a semi-structured questionnaire and shared by 10 Italian reference centers of the Italian Network for Hereditary and Acquired Angioedema (ITACA). RESULTS: The proportion of symptomatic patients increased significantly after puberty (98.2% vs 83.9%, p=0.002 in males; 96.3% vs 68,4%, p<0.001 in females); the monthly mean of acute attacks was significantly higher after puberty, and this occurred both in females (median (IQR) = 0.41(2) in the three years before puberty vs 2(2.17) in the three years after, p<0.001) and in males (1(1.92) vs 1.25(1.56) respectively, p<0.001). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
16por Triggianese, P., Senter, R., Petraroli, A., Zoli, A., Lo Pizzo, M., Bignardi, D., Di Agosta, E., Agolini, S., Arcoleo, F., Rossi, O., Modica, S., Greco, E., Chimenti, M. S., Spadaro, G., De Carolis, C., Cancian, M.“…METHODS: C1INH-HAE women who experienced at least 1 pregnancy were included from seven centers of the Italian Network for Hereditary and Acquired Angioedema (ITACA). The interview study retrospectively analyzed pregnancies who underwent (group 1) or not (group 2) pdC1INH. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
17por Casadei-Gardini, Andrea, Scarpi, Emanuela, Ulivi, Paola, Palladino, Maria Angela, Accettura, Caterina, Bernardini, Ilaria, Spallanzani, Andrea, Gelsomino, Fabio, Corbelli, Jody, Marisi, Giorgia, Ruscelli, Silvia, Valgiusti, Martina, Frassineti, Giovanni Luca, Passardi, Alessandro“…Aim: The aim of this study was to investigate the role of a new inflammatory index (Colon Inflammatory Index [CII]) as a predictor of prognosis and treatment efficacy in patients with metastatic colorectal cancer (mCRC) enrolled in the prospective multicenter randomized ITACa (Italian Trial in Advanced Colorectal Cancer) trial to receive first-line chemotherapy (CT)+ bevacizumab or CT alone. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
18
-
19
-
20